Ablynx: Corporate Presentation (Ablynx) - Sep 26, 2013 - Anticipated initiation of P1 SC safety study for rheumatoid arthritis in 2014; Anticipated initiation of P2b trial for rheumatoid arthritis in 2015; Anticipated top line results from P2b trial for rheumatoid arthritis in 2016
Anticipated new P1 trial • Anticipated new P2b trial • Anticipated P2b data • Immunology • Rheumatoid Arthritis
|